The aim of this study is to evaluate the clinical outcomes of etanercept in rheumatoid arthritis patients with moderate or severe disease activity.
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register
ADAMI, Silvano;
2014-01-01
Abstract
The aim of this study is to evaluate the clinical outcomes of etanercept in rheumatoid arthritis patients with moderate or severe disease activity.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.